Prof. Dan Greenberg

Prof. Dan Greenberg Profile

PhD, 2001

Department : Department of Health Systems Management
Health Systems Management
Room : 306
בנין משרדי רפואה ע"ש אליה
Phone : 972-8-6477422
Email :
Office Hours :  
health economics, cost effectiveness, quality of life


  • 2001-2004 - Post-doctoral research fellowship. Harvard Clinical Research Institute & Cardiovascular Division, Department of Medicine, Beth Israel-Deaconess Medical Center, Harvard Medical School. Advisor: Prof. David J. Cohen 2001 - Ph.D. - Ben-Gurion University of the Negev, Faculty of Health Sciences, Department of Health Systems Management. Thesis: Adoption and Diffusion of Technologies in Israeli Medical Centers in an Era of Budget Constraints. Advisors: Prof. Joseph Pliskin, Dr. Daniel Vekstein & Dr. Yitzhak Peterburg. 1996 - M.Sc - Ben-Gurion University of the Negev, Department of Industrial Engineering and Management/Health Policy and Management (graduated Magna Cum Laude). Thesis: Cost-Utility Analysis of Implantable Cardioverter Defibrillator Therapy. Advisors: Prof. J. Pliskin & Prof. D. Pilpel 1992 - B.A. - Open University, Social Sciences

Research Interests

  • Health technology assessment, outcomes research, economic evaluation of medical technologies, cost-effectiveness analysis, cost-benefit analysis, decision analysis

Research Topics

  • Economic evaluation of healthcare technologies
  • Contingent valuation/willingness to pay
  • Diffusion and adoption of medical technologies. iv. Value-based insurance design v. Reimbursement policies

Major expertise and techniques in the lab

  • Cost-effectiveness analysis
  • Outcomes research and quality of life assessment
  • Contingent valuation/willingness to pay

Publications and funding summary / representative publications and grants

  • Hammerman A, Feder-Bubis P, Greenberg D . Perceived incentives for adopting a financial risk-sharing scheme in Israel . Value in Health 2012; 15: 737-742 . Neumann PJ, Auerbach H, Cohen JT, Greenberg D . Low-value services in value-based insurance design. Am J Manag Care; 2010;16:280-286. Greenberg D , Earle C, Fang C, Eldar-Lissai A, Neumann PJ. When is cancer care cost-effective? A systematic overview of cost-utility analyses in oncology. J Natl Cancer Inst ; 2010; 102: 82-88 . Greenberg D (PI), Neumann PJ (PI), Hammerman A, Shani A. What is the value of a quality adjusted life year in cancer patients in Israel ? Study supported by the Israel National Institute for Health Policy and Health Services Research.

Existing collaborations

  • Peter J. Neumann, Tufts Medical Center , Boston , MA . Willingness to pay for cancer care. Tzahit Simon-Tuval, Ben-Gurion University . Value-based co-payment.